ArisGlobal completed the acquisition of Amplexor Life Sciences from Acolad.

ArisGlobal, a provider of life sciences software, completed the acquisition of Amplexor Life Sciences, a provider of regulatory, quality, and safety software solutions, from Acolad, a provider of a full suite of content and language solutions, services and technology. Financial terms were not disclosed. "For many years, ArisGlobal has been focused on building a regulatory platform that provides a market-leading, comprehensive set of products and streamlines processes supporting collaboration across distributed teams while adhering to extensive and evolving global regulatory requirements. By combining our core functionalities, we are elevating our end-to-end Regulatory capabilities to enhance our customers' journey," Mike Gordon, ArisGlobal CEO.